Nabla, the leading ambient AI assistant for practitioners, announced the initial close of a $24M Series B funding round led by Cathay Innovation, with participation from ZEBOX Ventures. This close brings Nabla’s total funding to over $43M. This investment enables Nabla to boost expansion across U.S. healthcare systems and continue transforming the way providers deliver care with its ambient AI assistant.
Clinicians have deemed managing the electronic health record (EHR) the biggest stressor in patient care. Clinical documentation is a time-intensive task that adds six hours per week of EHR work for practitioners outside of standard time spent with patients. With its AI-powered note-generation capabilities, medical coding recognition, and smooth EHR integrations, Nabla Copilot is saving clinicians valuable time so they can focus on caring for their patients. Providers claim the notes are remarkable for their precision, with only 5% requiring adjustments.
Also Read: Jorie AI’s Vibrant Debut at HLTH 2023: The Future of Healthcare Revenue Cycle Management
“This fundraise allows us to continue delivering on our vision to build the premier ambient AI assistant that will allow clinicians to experience the joy of practicing again,” said Alex Lebrun, co-founder and CEO, Nabla. “Clinical documentation is only the beginning for Nabla. Health systems are looking to leverage the AI opportunity to support their healthcare teams in many different aspects; we are getting ready to be there every step of the way.”
“Nabla’s exceptional team understands clinicians’ pain points and has the deep, technical expertise needed to bring cutting-edge AI and LLM technologies to the healthcare industry and best support practitioners shifting back to a patient-centric approach,” said Jacky Abitbol, Managing Partner, Cathay Innovation. “The company has demonstrated impressive early traction in both Europe and the US, and we look forward to putting our global network and resources to work to help Nabla expand further and solidify their position at the heart of new AI medical applications.”
SOURCE: PRNewswire
